IGF-1 LR3 + Ipamorelin + BPC-157 Athletic Performance Stack

IGF-1 LR3 (Long Arg3 Insulin-like Growth Factor-1) is a modified IGF-1 analog with a 13-amino-acid extension at the N-terminus and an arginine substitution at position 3. These modifications extend its half-life from minutes (native IGF-1) to approximately 20-30 hours and reduce binding to IGF binding proteins (IGFBPs), resulting in significantly greater bioavailability at the IGF-1 receptor. The anabolic potency of IGF-1 LR3 is well-established in cell culture and animal models — it drives both muscle hypertrophy (through mTOR-mediated protein synthesis) and hyperplasia (through satellite cell proliferation and differentiation).

Ipamorelin is a selective growth hormone secretagogue that activates the ghrelin receptor (GHS-R1a) without raising cortisol or prolactin — a crucial distinction from earlier secretagogues like GHRP-6. The GH pulse from ipamorelin enhances recovery between training sessions, supports collagen synthesis for connective tissue resilience, and improves deep sleep (GH is predominantly released during slow-wave sleep). BPC-157 completes the stack by addressing the tissue damage that limits training volume and intensity: tendon strain, ligament stress, muscle micro-tears, and joint inflammation.